The store will not work correctly when cookies are disabled.
6-Chloro-N'-(2-hydroxy-3-methoxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide
ID: ALA4528193
PubChem CID: 146000664
Max Phase: Preclinical
Molecular Formula: C18H13ClN2O6
Molecular Weight: 388.76
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(C(=O)NNC(=O)c2cc3cc(Cl)ccc3oc2=O)c1O
Standard InChI: InChI=1S/C18H13ClN2O6/c1-26-14-4-2-3-11(15(14)22)16(23)20-21-17(24)12-8-9-7-10(19)5-6-13(9)27-18(12)25/h2-8,22H,1H3,(H,20,23)(H,21,24)
Standard InChI Key: IBKVQEMPVNQAOP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
14.8731 -7.6436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8720 -8.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5800 -8.8721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5782 -7.2347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2868 -7.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2857 -8.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9958 -8.8765 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7116 -8.4672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7128 -7.6420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9981 -7.2261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4181 -8.8778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4215 -7.2352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1282 -7.6455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4235 -6.4180 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8369 -7.2386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5436 -7.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2523 -7.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5416 -8.4662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9554 -7.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6636 -7.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6661 -6.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9544 -6.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2491 -6.4290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9512 -8.4721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3701 -7.6594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0790 -7.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1653 -7.2352 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
19 24 1 0
20 25 1 0
25 26 1 0
1 27 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 388.76 | Molecular Weight (Monoisotopic): 388.0462 | AlogP: 2.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 117.87 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.36 | CX Basic pKa: ┄ | CX LogP: 2.62 | CX LogD: 2.58 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.47 | Np Likeness Score: -0.88 |
References
1. Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R.. (2019) Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors., 10 (1): [PMID:30774857] [10.1039/C8MD00328A] |